Quick Takeaways
- This page summarizes James P. Mackin's Form 4/A filing for ARTIVION, INC. (AORT).
- 4 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 14 Mar 2024, 20:14.
James P. Mackin - 23 Feb 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)
- Role
- President & CEO
- Signature
- /s/ James P. Mackin
- Issuer symbol
- AORT
- Transactions as of
- 23 Feb 2024
- Net transactions value
- -$625,080
- Form type
- 4/A
- Filing time
- 14 Mar 2024, 20:14:50 UTC
- Date Of Original Report
- 28 Feb 2024
- Previous filing
- 22 Feb 2024
- Next filing
- 14 Mar 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"James P. Mackin filed Form 4/A for ARTIVION, INC. (AORT) on 14 Mar 2024."
What Changed
- Previous filing in this sequence was filed on 22 Feb 2024.
- Current net transaction value: -$625,080.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Award | $0 | +40,404 | +6.4% | $0.000000 | 668,441 | 23 Feb 2024 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $362,204 | -17,868 | -2.7% | $20.27 | 650,573 | 26 Feb 2024 | Direct | F2, F3 |
| transaction | AORT | Common Stock | Award | $0 | +58,648 | +9% | $0.000000 | 709,221 | 23 Feb 2024 | Direct | F3, F4 |
| transaction | AORT | Common Stock | Sale | $262,876 | -12,968 | -1.8% | $20.27 | 696,253 | 26 Feb 2024 | Direct | F3, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. |
| F2 | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 18,144 shares were sold, when in fact, 17,868 shares were sold. |
| F3 | As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. |
| F4 | Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. |
| F5 | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 13,168 shares were sold, when in fact, 12,968 shares were sold. |